Newer classes of diabetes drugs reliably protect patients from heart and kidney damage associated with type 2 diabetes and chronic kidney disease, an American Heart Association analysis finds. Increased use may help the medical community kickstart stalled progress in treating these patients, the authors say.
Vitamin D treatment in adults with low levels but no symptoms of deficiency has no effect on most health outcomes, including fractures, depression and diabetes, a new analysis shows.
Omega-3 supplements should be a standard preventive treatment for people with cardiovascular disease or who are recovering from heart attack, a new study reveals.
A seven-year trial shows that the phosphate binder lanthanum carbonate (Fosrenol) does not reduce cardiovascular risk for late-stage renal patients, researchers say.
Multimorbidity and polypharmacy puts individuals at a higher risk of testing positive for COVID-19, a new study has found. People of color were also three times as likely to test positive as a white cohort.
The risk of dying from a heart attack or stroke was lower by 20% in elders who took statins. In fact, age and dementia diagnosis had no bearing on statin benefits, say researchers.
Social isolation ‘cannot become the new normal,’ say senators … Some states see new spike in COVID-19 cases, hospitalizations … Half of hospitalized COVID-19 patients develop neurological problems … Low-dose aspirin lowers cardiovascular risk, but bleeding a problem: new evidence
Higher cardiovascular risk is tied to cognitive decline and neurodegeneration, a study spanning more than two decades has found.
Monitoring blood pressure changes during and after exercise may help identify the odds of developing hypertension and cardiovascular disease, say researchers.
Behavioral counseling including diet and physical activity interventions is tied to significantly reduced risk for cardiovascular events, finds a new review
